Phase I Report of Task I Preclinical Intravenous Toxicity Study of N-methylformamide (NSC 3051) in CD2F1 Mice and Beagle Dogs (Amendment I)

摘要

In reporting the results of the studies conducted on N-methylformamide (NSC-3051) at Southern Research Institute, two reports were written. The Phase I report was submitted to Battelle's Toxicology Program Office (TPO) on November 3, 1981. The final Phase II report was accepted by the TPO office May 19, 1982. The purpose of this amendment is to address each of the discrepancies that occurred between the Phase I and Phase II report.